Company news
Polaris Group news in 2023
Polaris Group's news releases, calls and decks from 2023, newest first.
Polaris Group Announced the Acquisition of Genovior Biotech, Initiating Dual-Engine Growth
December 21, 2023
Polaris Group Initiates Phase 3 Trial: First Patient Successfully Dosed with ADI-PEG 20/Placebo plus Gemcitabine and Docetaxel for Difficult-to-Treat Leiomyosarcoma (LMS)
December 4, 2023
Polaris Group Announces First Patient Successfully Dosed with ADI-PEG 20/Placebo in Phase 2a Non-Alcoholic Steatohepatitis (NASH) Study
November 29, 2023
Polaris Group Initiates Rolling Submission of Biologic License Application (BLA) for ADI-PEG 20 with U.S. FDA to Treat Malignant Pleural Mesothelioma
November 16, 2023